Morning Trend | HEALTHYWAY INC's trading volume expands, can it stabilize at the support range?

As of the close on December 5th, HEALTHYWAY INC (2587.HK) showed an unfavorable performance. The market was clearly under pressure yesterday, with intensified capital outflow, and the day was dominated by selling. Although there were some sporadic buybacks towards the end of the trading session, the overall rebound lacked sustained momentum. The MACD daily trend continues to tighten, with short, medium, and long-term moving averages all trending downward, and bearish sentiment is rising. Since the company's monthly operational briefing was released last week, industry confidence has not improved, and there are widespread concerns about the recent policy vacuum in the pharmaceutical sector and external instability, leading to a growing atmosphere of capital hesitation. The overall sentiment in the healthcare sector remains negative, with previous high holders showing a strong willingness to cut losses, resulting in continued selling pressure. Recently, the A-share pharmaceutical theme has been in continuous decline, which has also affected the performance of similar sectors in the Hong Kong stock market, with multiple stocks declining simultaneously, exacerbating short-term pessimism within the industry. Yesterday's trading volume significantly increased, interpreted by the market as a concentrated release of panic selling. Prices have approached the lower band of the Bollinger Bands, with significant pressure at short-term support levels, limiting price elasticity. Technically, attention should be paid to whether the previous low area can be maintained; if there is a breakout with increased volume, the likelihood of further downward probing will increase. Unless there are new favorable policies or leading capital reverses the trend and buys back, the bottom entanglement state is difficult to change. Right-side trading users are advised to pay more attention to signals of stopping the decline and intraday capital inflow, focusing on risk control at this stage. If there is marginal improvement in pharmaceutical policies or main capital replenishment, HEALTHYWAY INC may have the potential to stabilize and strengthen. In the short term, it is advisable to be cautious and observe closely the trading volume and capital movements to prevent a secondary market crash